Valeant Pharma (VRX), Progenics (PGNX) Announce Commercial Launch of RELISTOR as OIC Treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/17/2024
Go back to Valeant Pharma (VRX), Progenics (PGNX) Announce Commercial Launch of RELISTOR as OIC Treatment
September 7, 2016 4:42 PM EDT
Valeant Pharma (NYSE: VRX) CEO Joe Papa said more news on asset sales will be coming near the end of this year, according to commentary on CNBC today.
Papa also won't rule out a Bausch + Lomb sale.
...
More